Posts Tagged ‘FDA’
Florida Oncologist Charged With Medicare Fraud and Buying Cancer Medication from Known Counterfeit Drug Seller
Dr. Anda Norbergs was the head doctor, owner, and operator of East Lake Oncology (ELO), a cancer treatment clinic located in Palm Harbor. Beginning at around June 2009, it is alleged that she began ordering drugs from foreign distributors, including CanadaDrugs subsidiary Quality Specialty Products (QSP). The drugs she purchased included drugs from foreign businesses…
[...]Canada-based Company that Acted as Drop-Shipper Pays $33 Million Fine in Misbranded Drug Smuggling Case
A Federal Court in Virginia has accepted the guilty plea of SB Medical Inc. and TC Medical Group on charges that they indulged in a multi-year conspiracy to smuggle and sell misbranded prescription pharmaceuticals in the United States and unlicensed wholesaling of prescription drugs. SB Medical Inc. was based in Toronto, Canada, and TC Medical…
[...]Texas Physician Pleads Guilty to Importing Cancer Medication from Supplier of Fake Avastin
On April 23, 2015, Dr. Mohamed Ayman Ghraowi pleaded guilty to charges that he and his South Texas Comprehensive Cancer Centers PLLC caused the introduction into interstate commerce of misbranded prescription cancer drugs worth more than $900,000, from CanadaDrugs subsidiary Montana Healthcare Solutions. His indictment noted that he purchased misbranded cancer drugs from Montana Healthcare…
[...]Utah Cancer Treatment Center and Clinic Owner Plead Guilty to Buying from Counterfeit Drug Supplier QSP
In April 2015, Dr. Ali Ben-Jacob pleaded guilty to importing misbranded cancer medication from CanadaDrugs subsidiary Quality Specialty Products (QSP). His Cache Valley Cancer Treatment and Research Clinic also pleaded guilty to purchasing the misbranded cancer drugs and resolved a civil claim with the Department of Justice brought on behalf of the FDA and federal…
[...]Manteca Oncologist Pays $550,000 to Settle False Claims Act Charges Pertaining to Fake Cancer Drug Purchases
Dr. Prabhjit S. Purewal agreed to pay $550,000 to settle allegations that he improperly billed Medicare for a variety of chemotherapy drugs purchased from unlicensed foreign pharmaceutical distributor, Richards Pharma. Richards Pharma, or Warwick Healthcare Solutions was an unsanctioned pharmaceutical distributor that was a source of counterfeit Altuzan. Who: U.S. Department of Health and Human…
[...]Two Officers of Turkish Pharmaceutical Importer Sentenced in Counterfeit Cancer Medication Case
Two senior officers for the Turkish importer Ozay Pharmaceuticals have pleaded guilty in U.S. court and been sentenced for their role in supplying U.S. medical practices with counterfeit versions of the cancer medication Altzuan. Foreign Trade Director Ozkan Semizoglu has been sentenced to 27 months in prison, and owner and manager Sabahaddin Akman has been…
[...]Is it Safe For Americans to Order Life-Saving Medicine From Online Pharmacies Overseas?
Click image to download G-8 Infographic (pdf) The countries of the Group of 8 (G8) have begun to work together to try and fight the global scourge of counterfeit medications. Their efforts are important, as most of the G8 member countries are having their own problems with counterfeit drug crime. In May 2013 leaders from…
[...]FDA Warns Consumers to Beware Bogus Diabetes Treatments
Images of bogus diabetes treatments courtesy of the FDA. The U.S. Food and Drug Administration (FDA) is warning diabetics to beware of illegal “natural” remedies for the treatment of diabetes. They pose a serious health danger to diabetics, and are part of the growing trend amongst drug counterfeiters pushing fake natural medications. The FDA has…
[...]Fake Botox on the Rise in US as FDA Warnings and Recent Arrest Indicate
In 2012, the FDA sent over 350 warning letters to doctors advising them they may have purchased fraudulent or misbranded injectable drugs, including fake versions of Avastin, Botox, and two different osteoporosis treatments. Now the FDA has identified another batch of fake Botox that is currently being marketed to doctor via fax blast.
On April 26, 2013, the US Food and Drug Administration (FDA) posted a drug safety warning for healthcare practitioners, warning them that fraudulent versions of the anti-wrinkle treatment Botox are being marketed and sold in the US. The Botox is being sold by unlicensed suppliers, and has not been vetted within the secure U.S. supply chain. They state that the FDA “cannot confirm that the manufacture, quality, storage, and handling of these products follow U.S. standards. These fraudulent products are considered unsafe and should not be used.“
[...]FDA Warns Consumers Not to Use Stolen Advair Inhalers
The U.S. Food and Drug Administration (FDA) has issued a warning that a number of Advair Diskus inhalers that were stolen in 2009 have been found in some pharmacies and that consumers should not used the stolen products. The products were reported stolen from a GlaxoSmithKline warehouse near Richmond, Virginia, in August 2009. These recently…
[...]